Loading company…
N.B.Medical develops medical devices and technologies for treating cerebrovascular diseases.
N.B.Medical develops devices and technologies for cerebrovascular disease treatment, including endovascular devices, coatings, and digital tools. It also conducts research and development to improve patient care. Based in Tokyo, Japan, it raised JPY 850 million in Series B funding in March 2026 from AIST Solutions, Neuroceuticals Inc., Mitsubishi UFJ Capital, Red Capital, Yokowo co., ltd., ANRI, JAFCO Group, and Reazon Holdings; the round was part of a larger JPY 3.35 billion Series B.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in